Huawei Launches AI-Centric 5.5G Solutions to Ignite the Mobile AI Era

SHENZHEN, China, March 10, 2025 /PRNewswire/ — At the Huawei Product &…

HD Hyundai Executive Vice Chairman Chung Kisun meets with Palantir CEO Alex Karp to discuss 'AI Shipyard'

SEOUL, South Korea, March 10, 2025 /PRNewswire/ — HD Hyundai Executive Vice…

Collinson International partners with China Ping An Insurance (Hong Kong) to provide airport lounge access and alternative benefits during flight delays and cancellations

The partnership provides Collinson International’s SmartDelay™ solution as a complimentary benefit for China…

Doer Biologics Completes Enrollment of the Phase 2 Clinical Study of DR10624 for Treatment of Severe Hypertriglyceridemia

HANGZHOU, China, March 10, 2025 /PRNewswire/ — Zhejiang Doer Biologics Co., Ltd.…

Thai Scientists from Chula to Investigate Global Warming in Antarctica

BANGKOK, March 10, 2025 /PRNewswire/ — Prof. Dr. Suchana Chavanich from the Department…

HASHKEY GLOBAL PARTNERS WITH VERIFYVASP TO EXPAND GLOBAL TRAVEL RULE COMPLIANCE

Strategic partnership strengthens regulatory compliance across HashKey Global’s international exchange network. SINGAPORE,…

Webull Singapore launches trading competition for Singapore traders

SINGAPORE, March 10, 2025 /PRNewswire/ — Webull Securities (Singapore) Pte Ltd ("Webull Singapore"), a…

RiboX Therapeutics Announces First Patient Dosed in Phase I/IIa Clinical Trial of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation

PRINCETON, N.J., March 10, 2025 /PRNewswire/ — RiboX Therapeutics Ltd. (RiboX), a pioneering…